Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas
- PMID: 15538750
- DOI: 10.1002/path.1662
Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas
Abstract
Hepatoblastoma (HB) is the most frequent malignant liver tumour of childhood. Most HBs develop sporadically but their incidence is highly elevated in patients with familial adenomatous polyposis coli (FAP). These patients carry germline mutations in the adenomatous polyposis coli (APC) tumour suppressor gene. APC forms a multi-protein complex involved in the WNT signalling pathway that controls the stability of beta-catenin, the central effector in this cascade. Whereas APC mutations are rare in sporadic HBs, a high frequency of beta-catenin mutations leading to overactivation of WNT signalling was previously found in these tumours. This pathway is negatively controlled by conductin (axin2), representing a further partner in this signalling complex. To investigate whether alterations in conductin may also be involved in the pathogenesis of sporadic HBs, 37 HBs and five HB cell lines were screened for mutations using single-strand conformation polymorphism (SSCP) analysis, reverse transcription-polymerase chain reaction (RT-PCR), and direct sequencing. In two cases, larger deletions (52 and 1624 bp) leading to frameshifts were found. In addition, one HB carried a somatic point mutation. Expression analysis by competitive RT-PCR in HBs revealed up-regulation of conductin mRNA compared with adjacent liver samples. This mRNA overexpression resulted in increased conductin protein levels demonstrated by western blot analysis. Tumours with activating beta-catenin mutations revealed higher levels of conductin mRNA transcripts. This finding indicates that conductin is a direct target gene of WNT signalling in HBs, as has been demonstrated in other tissues. In summary, conductin mutations may represent an alternative mechanism leading to activation of WNT signalling in HBs. The overexpression of conductin mRNA in HBs reflects activation of the WNT pathway because conductin represents a target gene of WNT signalling in liver tissue.
Copyright (c) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.Cancer Res. 1999 Jan 15;59(2):269-73. Cancer Res. 1999. PMID: 9927029
-
Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.Int J Cancer. 2007 Jul 15;121(2):284-91. doi: 10.1002/ijc.22675. Int J Cancer. 2007. PMID: 17373666
-
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.Oncogene. 2002 Jul 18;21(31):4863-71. doi: 10.1038/sj.onc.1205591. Oncogene. 2002. PMID: 12101426
-
Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.Oncol Rep. 2004 Jan;11(1):121-6. Oncol Rep. 2004. PMID: 14654913 Review.
-
Colorectal cancer and genetic alterations in the Wnt pathway.Oncogene. 2006 Dec 4;25(57):7531-7. doi: 10.1038/sj.onc.1210059. Oncogene. 2006. PMID: 17143297 Review.
Cited by
-
Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.Carcinogenesis. 2013 May;34(5):953-61. doi: 10.1093/carcin/bgt018. Epub 2013 Jan 25. Carcinogenesis. 2013. PMID: 23354304 Free PMC article.
-
β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.J Biol Chem. 2019 Nov 15;294(46):17524-17542. doi: 10.1074/jbc.RA119.009979. Epub 2019 Oct 9. J Biol Chem. 2019. PMID: 31597698 Free PMC article.
-
AXIN1 and AXIN2 variants in gastrointestinal cancers.Cancer Lett. 2014 Dec 1;355(1):1-8. doi: 10.1016/j.canlet.2014.09.018. Epub 2014 Sep 16. Cancer Lett. 2014. PMID: 25236910 Free PMC article. Review.
-
The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma.Cancers (Basel). 2019 Sep 20;11(10):1406. doi: 10.3390/cancers11101406. Cancers (Basel). 2019. PMID: 31547062 Free PMC article. Review.
-
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Cancers (Basel). 2017 Sep 20;9(9):127. doi: 10.3390/cancers9090127. Cancers (Basel). 2017. PMID: 28930164 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous